Vindesine in the treatment of refractory hematologic malignancies: A phase II study-Reference-Cited by-同舟云学术

Vindesine in the treatment of refractory hematologic malignancies: A phase II study

Published:1982-01 Issue:5 Volume:6 Page:649-652
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Mandelli Franco,Amadori Sergio,Giona Fiorina,Antonietta Maria,Spiriti Aloe,Pastore Simonetta,Meloni Giovanna,Paolucci Guido

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference7 articles.

1. Phase-II trial with vindesine for regression induction in patients with leukemia and hematosarcomas;Bayssas;Cancer Chemother.,1979

2. Initial clinical studies of vindesine (desacetyl vinblastine amide sulphate);Bodey,1976

3. Vindesine: a short review of preclinical and first clinical data;Dyke;Cancer Chemother. Pharmac.,1979

4. A phase II study of vindesine in patients with hematological malignancies;Hulhoven;Biomedicine,1980

5. Phase-II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma and Hodgkin's disease;Mathe,1978

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronische myeloische Leukämie (CML);Kompendium Internistische Onkologie;2006

2. Correlation between cell survival and micronuclei formation in V79 cells treated with vindesine before exposure to different doses of γ-radiation;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2000-03

3. Influence of vindesine exposure on the micronucleus formation and cell survival in V79 cells;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;1998-10

4. Enhancement of micronuclei frequency by vindesine in mouse bone marrow;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;1997-01

5. Vindesine in the Treatment of Leukaemia;Leukemia & Lymphoma;1997-01